NASDAQ: RADX
Radiopharm Theranostics Ltd Stock Forecast, Predictions & Price Target

Analyst price target for RADX

Based on 1 analyst offering 12 month price targets for Radiopharm Theranostics Ltd

Min Forecast
$16.00+271.23%
Avg Forecast
$16.00+271.23%
Max Forecast
$16.00+271.23%

Should I buy or sell RADX stock?

Based on 1 analyst offering ratings for Radiopharm Theranostics Ltd.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their RADX stock forecasts and price targets.

RADX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-06-04

1 of 1

RADX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
RADX$4.31$16.00+271.23%Buy
DARE$2.05N/AN/A
LITS$0.89N/AN/A
SNTI$0.98$12.00+1,130.77%Strong Buy
SDEV$1.14N/AN/A

Radiopharm Theranostics Stock Forecast FAQ

Is Radiopharm Theranostics Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: RADX) stock is to Buy RADX stock.

Out of 1 analyst, 0 (0%) are recommending RADX as a Strong Buy, 1 (100%) are recommending RADX as a Buy, 0 (0%) are recommending RADX as a Hold, 0 (0%) are recommending RADX as a Sell, and 0 (0%) are recommending RADX as a Strong Sell.

If you're new to stock investing, here's how to buy Radiopharm Theranostics stock.

What is RADX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year RADX price target, the average RADX price target is $16.00, with the highest RADX stock price forecast at $16.00 and the lowest RADX stock price forecast at $16.00.

The Wall Street analyst predicted that Radiopharm Theranostics's share price could reach $16.00 by Jun 4, 2027. The average Radiopharm Theranostics stock price prediction forecasts a potential upside of 271.23% from the current RADX share price of $4.31.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.